Relationship between the level of vitamin D in bloof flow and skin dermatosis

Abstract

Vitamin D is vital for bone health and its deficiency deemed as a disease of the past has re-emerged as an important health concern. Thanks to modern research, the role of vitamin D has been studied in detail and goes far beyond the concepts of regulating the mineral composition of bones. A small amount of active vitamin in the form of cholecalciferol is obtained by the body with food of animal origin, in the form of ergocalciferol and previtamin D ― with food of plant origin. Another way to get vitamin D is exposure to solar radiation. Both insufficient and excessive levels of vitamin D have adverse effects on the body. A constant blood level above 200 ng/ml is considered toxic and is manifested by anorexia, weight loss, polyuria and cardiac arrhythmia. Vitamin D toxicity increases the risk of kidney stones, calcification of blood vessels and tissues, as well as complications associated with these changes.

The growing interest in the role played by vitamin D in skin disease has given rise to the publication of many studies of the relationship between this vitamin and cutaneous dermatoses. Undoubtedly, a complete understanding of the synthesis of vitamin D, the main sources of its production by the body, indicators of the normal content of vitamin D levels in the blood, as well as factors that can influence their changes, are important. Of particular interest are the latest discoveries about the role of vitamin D in skin diseases such as lupus erythematosus, ichthyosis, atopic dermatitis, hidradenitis suppurativa, acne, alopecia areata, androgenetic alopecia, melanoma, and nonmelanoma skin cancer.

Also of interest is the importance of vitamin D as adjuvant therapy in patients on long-term treatment with corticosteroids. In this review, we provide an overview of the most important and most recent information regarding the relationship between vitamin D and skin disease and discuss the importance of assessing individual vitamin D status and correcting deficiencies.

Keywords

vitamin D / psoriasis / atopic dermatitis / ichthyosis / acne / hidrosadenitis supurativa / vitiligo / alopecia areata / melanoma / skin cancer

References

[1] Charpy J. A propos du traitement du lupus tuberculeux; une question de priorité. Ann Dermatol Syphiligr. 1945;5:317.

[2] Charpy J. A propos du traitement du lupus tuberculeux; une question de priorité // Ann Dermatol Syphiligr. 1945. Vol. 5. P. 317.

[3] Navarro-Triviño FJ, Arias-Santiago S, Gilaberte-Calzada Y. Vitamin D and the skin: a review for dermatologists. Actas Dermo-Sifiliográficas (English Edition). 2019;110(4):262–272. doi: 10.1016/j.ad.2018.08.006

[4] Navarro-Triviño F.J., Arias-Santiago S., Gilaberte-Calzada Y. Vitamin D and the skin: a review for dermatologists // Actas Dermo-Sifiliográficas (English Edition). 2019. Vol. 110, N 4. Р. 262–272. doi: 10.1016/j.ad.2018.08.006

[5] Ross AC, Taylor CL, Yaktine AL, et al. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academy Press; 2011. doi: 10.17226/13050

[6] Ross A.C., Taylor C.L., Yaktine A.L., et al. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academy Press, 2011. doi: 10.17226/13050

[7] Seamans K, Cashman K. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr. 2009;89(6):1997s–2000s. doi: 10.3945/ajcn.2009.27230D

[8] Seamans K., Cashman K. Existing and potentially novel functional markers of vitamin D status: A systematic review // Am J Clin Nutr. 2009. Vol. 89, N 6. P. 1997s–2000s. doi: 10.3945/ajcn.2009.27230D

[9] Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi: 10.1210/jc.2011-0385

[10] Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline // J Clin Endocrinol Metab. 2011. Vol. 96, N 7. P. 1911–1930. doi: 10.1210/jc.2011-0385

[11] Spiro A, Buttriss JL. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull. 2014;39(4):322–350. doi: 10.1111/nbu.12108

[12] Spiro A., Buttriss J.L. Vitamin D: an overview of vitamin D status and intake in Europe // Nutr Bull. 2014. Vol. 39, N 4. P. 322–350. doi: 10.1111/nbu.12108

[13] Olisova OY, Vladimirova EV, Babushkin AM. The skin and the sun. Russian Journal of Skin and Venereal Diseases. 2012;6:57–63. (In Russ).

[14] Олисова О.Ю., Владимирова Е.В., Бабушкин А.М. Кожа и солнце // Российский журнал кожных и венерических болезней. 2012. № 6. C. 57–63.

[15] Kechichian E, Ezzedine K. Vitamin D and the skin: an update for dermatologists. Am J Clin Dermatol. 2018;19(2):223–235. doi: 10.1007/s40257-017-0323-8

[16] Kechichian E., Ezzedine K. Vitamin D and the skin: An update for dermatologists // Am J Clin Dermatol. 2018. Vol. 19, N 2. P. 223–235. doi: 10.1007/s40257-017-0323-8

[17] Bikle D. Extraskeletal actions of vitamin D. Ann N Y Acad. 2016;1376(1):29–52. doi: 10.1111/nyas.13219

[18] Bikle D. Extraskeletal actions of vitamin D // Ann N Y Acad. 2016. Vol. 1376, N 1. P. 29–52. doi: 10.1111/nyas.13219

[19] Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–1428. doi: 10.2337/dc12-0962

[20] Song Y., Wang L., Pittas A.G., et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies // Diabetes Care. 2013. Vol. 36, N 5. P. 1422–1428. doi: 10.2337/dc12-0962

[21] Inomata S, Kadowaki S, Yamatani T, et al. Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner. 1986;1(3):187–192.

[22] Inomata S., Kadowaki S., Yamatani T., et al. Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus // Bone Miner. 1986. Vol. 1, N 3. P. 187–192.

[23] Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89(5):1321–1327. doi: 10.3945/ajcn.2008.27004

[24] Zittermann A., Frisch S., Berthold H.K., et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers // Am J Clin Nutr. 2009. Vol. 89, N 5. P. 1321–1327. doi: 10.3945/ajcn.2008.27004

[25] Zittermann A, Pilz S. Vitamin D and cardiovascular disease: an update. Anticancer Res. 2019;39(9):4627–4635. doi: 10.21873/anticanres.13643

[26] Zittermann A., Pilz S. Vitamin D and cardiovascular disease: an update // Anticancer Res. 2019. Vol. 39, N 9. Р. 4627–4635. doi: 10.21873/anticanres.13643

[27] Hammami MM, Yusuf A. Differential effects of vitamin D2 and D3 supplements on 25-hydroxyvitamin D level are dose, sex, and time dependent: a randomized controlled trial. BMC Endocr Disord. 2017;17:12. doi: 10.1186/s12902-017-0163-9

[28] Hammami M.M., Yusuf A. Differential effects of vitamin D2 and D3 supplements on 25-hydroxyvitamin D level are dose, sex, and time dependent: a randomized controlled trial // BMC Endocr Disord. 2017. Vol. 17. Р. 12. doi: 10.1186/s12902-017-0163-9

[29] Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, et al. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67(5):931–938. doi: 10.1016/j.jaad.2012.01.040

[30] Orgaz-Molina J., Buendía-Eisman A., Arrabal-Polo M.A., et al. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control study // J Am Acad Dermatol. 2012. Vol. 67, N 5. P. 931–938. doi: 10.1016/j.jaad.2012.01.040

[31] Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988. doi: 10.3390/nu12040988

[32] Grant W.B., Lahore H., McDonnell S.L., et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths // Nutrients. 2020. Vol. 12, N 4. P. 988. doi: 10.3390/nu12040988

[33] Hastie CE, Mackay DF, Ho F, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank Diabet Metab Syndr. Clin Res Rev. 2020;14(4):561–565. doi: 10.1016/j.dsx.2020.04.050

[34] Hastie C.E., Mackay D.F., Ho F., et al. Vitamin D concentrations and COVID-19 infection in UK Biobank Diabet Metab Syndr // Clin Res Rev. 2020. Vol. 14, N 4. P. 561–565. doi: 10.1016/j.dsx.2020.04.050

[35] Bergler-Czop B, Brzezińska-Wcislo L. Serum vitamin D level — the effect on the clinical course of psoriasis. Postepy Dermatol Alergol. 2016;33(6):445–449. doi: 10.5114/ada.2016.63883

[36] Bergler-Czop B., Brzezińska-Wcislo L. Serum vitamin D level — the effect on the clinical course of psoriasis // Postepy Dermatol Alergol. 2016. Vol. 33, N 6. P. 445–449. doi: 10.5114/ada.2016.63883

[37] Krafka G. Augusta. A simple treatment for psoriasis. J Lab Clin Med. 1936;21:1147–1148.

[38] Krafka G. Augusta. A simple treatment for psoriasis // J Lab Clin Med. 1936. Vol. 21. P. 1147–1148.

[39] Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–289. doi: 10.1016/j.det.2017.02.002

[40] Silverberg J.I. Public health burden and epidemiology of atopic dermatitis // Dermatol Clin. 2017. Vol. 35, N 3. P. 283–289. doi: 10.1016/j.det.2017.02.002

[41] Haeck IM, Hamdy NA, Timmer-de Mik L, et al. Low bone mineral density in adult patients with moderate to severe atopic dermatitis. Br J Dermatol. 2009;161(6):1248–1254. doi: 10.1111/j.1365-2133.2009.09327.x

[42] Haeck I.M., Hamdy N.A., Timmer-de Mik L., et al. Low bone mineral density in adult patients with moderate to severe atopic dermatitis // Br J Dermatol. 2009. Vol. 161, N 6. P. 1248–1254. doi: 10.1111/j.1365-2133.2009.09327.x

[43] Sethuraman G, Marwaha RK, Challa A, et al. Vitamin D: a new promising therapy for congenital ichthyosis. Pediatrics. 2016;137(6):1313. doi: 10.1542/peds.2015-1313

[44] Sethuraman G., Marwaha R.K., Challa A., et al. Vitamin D: a new promising therapy for congenital ichthyosis // Pediatrics. 2016. Vol. 137, N 6. P. 1313. doi: 10.1542/peds.2015-1313

[45] Noh S, Park CO, Bae JM, et al. Lower vitamin D status is closely correlated with eczema of the head and neck. J Allergy Clin Immunol. 2014;133:1767.e6–1770.e6. doi: 10.1016/j.jaci.2014.02.038

[46] Noh S., Park C.O., Bae J.M., et al. Lower vitamin D status is closely correlated with eczema of the head and neck // J Allergy Clin Immunol. 2014. Vol. 133. P. 1767.e6–1770.e6. doi: 10.1016/j.jaci.2014.02.038

[47] Cheon BR, Shin JE, Kim YJ, et al. Relationship between serum 25-hydroxyvitamin D and interleukin-31 levels, and the severity of atopic dermatitis in children. Korean J Pediatr. 2015;58:96–101. doi: 10.3345/kjp.2015.58.3.96

[48] Cheon B.R., Shin J.E., Kim Y.J., et al. Relationship between serum 25-hydroxyvitamin D and interleukin-31 levels, and the severity of atopic dermatitis in children // Korean J Pediatr. 2015. Vol. 58. P. 96–101. doi: 10.3345/kjp.2015.58.3.96

[49] Okano M. Assessment of the clinical effect of topical tacalcitol on ichthyoses with retentive hyperkeratosis. Dermatology. 2001;202(2):116–118. doi: 10.1159/000051609

[50] Okano M. Assessment of the clinical effect of topical tacalcitol on ichthyoses with retentive hyperkeratosis // Dermatology. 2001. Vol. 202, N 2. P. 116–118. doi: 10.1159/000051609

[51] Zouboulis CC, Seltmann H, Abdel-Naser MB, et al. Effects of extracellular calcium and 1.25 dihydroxyvitamin D3 on sebaceous gland cells in vitro and in vivo. Acta Derm Venereol. 2017;97(3):313–320. doi: 10.2340/00015555-2525

[52] Zouboulis C.C., Seltmann H., Abdel-Naser M.B., et al. Effects of extracellular calcium and 1.25 dihydroxyvitamin D3 on sebaceous gland cells in vitro and in vivo // Acta Derm Venereol. 2017. Vol. 97, N 3. P. 313–320. doi: 10.2340/00015555-2525

[53] Maynard MT. Vitamin D in acne: a comparison with X-ray treatment. Cal West Med. 1938;49(2):127–132.

[54] Maynard M.T. Vitamin D in acne: a comparison with X-ray treatment // Cal West Med. 1938. Vol. 49, N 2. P. 127–132.

[55] Lim SK, Ha JM, Lee Y, et al. Comparison of vitamin D levels in patients with and without acne: a case-control study combined with a randomized controlled trial. PloS One. 2016;11(8):e0161162. doi: 10.1371/journal.pone.0161162

[56] Lim S.K., Ha J.M., Lee Y., et al. Comparison of vitamin D levels in patients with and without acne: a case-control study combined with a randomized controlled trial // PloS One. 2016. Vol. 11, N 8. P. e0161162. doi: 10.1371/journal.pone.0161162

[57] El-Hamd MA, El Taieb MA, Ibrahim HM, Aly SS. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin. J Cosmet Dermatol. 2018;18(1):16–20. doi: 10.1111/jocd.12503

[58] El-Hamd M.A., El Taieb M.A., Ibrahim H.M., Aly S.S. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin // J Cosmet Dermatol. 2018. Vol. 18, N 1. P. 16–20. doi: 10.1111/jocd.12503

[59] Karagiannidis I, Nikolakis G, Sabat R, Zouboulis CC. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? Rev Endocr Metab Disord. 2016;17(3):335–341. doi: 10.1007/s11154-016-9366-z

[60] Karagiannidis I., Nikolakis G., Sabat R., Zouboulis C.C. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? // Rev Endocr Metab Disord. 2016. Vol. 17, N 3. P. 335–341. doi: 10.1007/s11154-016-9366-z

[61] Guillet A, Brocard A, Bach Ngohou K. et al. Verneuil’s disease, innate immunity and vitamin D: a pilot study. J Eur Acad Dermatol Venereol. 2015;29(7):1347–1353. doi: 10.1111/jdv.12857

[62] Guillet A., Brocard A., Bach Ngohou K., et al. Verneuil’s disease, innate immunity and vitamin D: a pilot study // J Eur Acad Dermatol Venereol. 2015. Vol. 29, N 7. P. 1347–1353. doi: 10.1111/jdv.12857

[63] Karagün E, Ergin C, Baysak S, et al. The role of serum vitamin D levels in vitiligo. Postepy Dermatol Alergol. 2016;33(4):300–302. doi: 10.5114/pdia.2016.59507

[64] Karagün E., Ergin C., Baysak S., et al. The role of serum vitamin D levels in vitiligo // Postepy Dermatol Alergol. 2016. Vol. 33, N 4. P. 300–302. doi: 10.5114/pdia.2016.59507

[65] Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology. 1998;197(2):167–170. doi: 10.1159/000017991

[66] Parsad D., Saini R., Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo // Dermatology. 1998. Vol. 197, N 2. P. 167–170. doi: 10.1159/000017991

[67] Khurrum H, AlGhamdi KM. The relationship between the serum level of vitamin D and vitiligo: a controlled study on 300 subjects. J Cutan Med Surg. 2016;20(2):139–145. doi: 10.1177/1203475415610071

[68] Khurrum H., AlGhamdi K.M. The relationship between the serum level of vitamin D and vitiligo: a controlled study on 300 subjects // J Cutan Med Surg. 2016. Vol. 20, N 2. P. 139–145. doi: 10.1177/1203475415610071

[69] Monticielo OA, Teixeira T, Chies JA, et al. Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin Rheumatol. 2012;31(10):1411–1421. doi: 10.1007/s10067-012-2021-5

[70] Monticielo O.A., Teixeira T., Chies J.A., et al. Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus // Clin Rheumatol. 2012. Vol. 31, N 10. P. 1411–1421. doi: 10.1007/s10067-012-2021-5

[71] Dall’Ara F, Cutolo M, Andreoli L, et al. Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects. Clin Exp Rheumatol. 2018;36(1):153–162.

[72] Dall’Ara F., Cutolo M., Andreoli L., et al. Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects // Clin Exp Rheumatol. 2018. Vol. 36, N 1. P. 153–162.

[73] Eloi M, Horvath DV, Ortega JC, et al. 25-hydroxyvitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients. PloS One. 2017;12(1):e0170323. doi: 10.1371/journal.pone.0170323

[74] Eloi M., Horvath D.V., Ortega J.C., et al. 25-hydroxyvitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients // PloS One. 2017. Vol. 12, N 1. P. e0170323. doi: 10.1371/journal.pone.0170323

[75] Hassanalilou T, Khalili L, Ghavamzadeh S, et al. Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation. Auto Immun Highlights. 2017;9(1):1–24. doi: 10.1007/s13317-017-0101-x

[76] Hassanalilou T., Khalili L., Ghavamzadeh S., et al. Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation // Auto Immun Highlights. 2017. Vol. 9, N 1. P. 1–24. doi: 10.1007/s13317-017-0101-x

[77] Schweintzger NA, Gruber-Wackernagel A, Shirsath N, et al. Influence of the season on vitamin D levels and regulatory T cells in patients with polymorphic light eruption. Photochem Photobiol Sci. 2016;15(3):440–446. doi: 10.1039/c5pp00398a

[78] Schweintzger N.A., Gruber-Wackernagel A., Shirsath N., et al. Influence of the season on vitamin D levels and regulatory T cells in patients with polymorphic light eruption // Photochem Photobiol Sci. 2016.Vol. 15, N 3. P. 440–446. doi: 10.1039/c5pp00398a

[79] Gruber-Wackernagel A, Bambach I, Legat FJ, et al. Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1.25-dihydroxyvitamin D3 analogue in polymorphic light eruption. Br J Dermatol. 2011;165(1):152–163. doi: 10.1111/j.1365-2133.2011.10333.x

[80] Gruber-Wackernagel A., Bambach I., Legat F.J., et al. Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1.25-dihydroxyvitamin D3 analogue in polymorphic light eruption // Br J Dermatol. 2011. Vol. 165, N 1. P. 152–163. doi: 10.1111/j.1365-2133.2011.10333.x

[81] Kim DH, Lee JW, Kim IS, et al. Successful treatment of alopecia areata with topical calcipotriol. Ann Dermatol. 2012;24(3):341–344. doi: 10.5021/ad.2012.24.3.341

[82] Kim D.H., Lee J.W., Kim I.S., et al. Successful treatment of alopecia areata with topical calcipotriol // Ann Dermatol. 2012. Vol. 24, N 3. P. 341–344. doi: 10.5021/ad.2012.24.3.341

[83] Orlow I, Shi Y, Kanetsky PA, et al.; GEM Study Group. The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival. Pigment Cell Melanoma Res. 2018;31(2):287–296. doi: 10.1111/pcmr.12653

[84] Orlow I., Shi Y., Kanetsky P.A., et al.; GEM Study Group. The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival // Pigment Cell Melanoma Res. 2018. Vol. 31, N 2. P. 287–296. doi: 10.1111/pcmr.12653

[85] Newton-Bishop JA, Davies JR, Latheef F, et al. 25-hydroxyvitamin D2/D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort. Int J Cancer. 2015;136(12):2890–2899. doi: 10.1002/ijc.29334

[86] Newton-Bishop J.A., Davies J.R., Latheef F., et al. 25-hydroxyvitamin D2/D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort // Int J Cancer. 2015. Vol. 136, N 12. P. 2890–2899. doi: 10.1002/ijc.29334

[87] Luo L, Orlow I, Kanetsky PA, et al.; GEM Study Group. No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival. PLoS One. 2017;12(3):e0174234. doi: 10.1371/journal.pone.0174234

[88] Luo L., Orlow I., Kanetsky P.A., et al.; GEM Study Group. No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival // PLoS One. 2017. Vol. 12, N 3. P. e0174234. doi: 10.1371/journal.pone.0174234

[89] Paolino G, Moliterni E, Corsetti P, et al. Vitamin D and melanoma: state of the art and possible therapeutic uses. Ital Dermatol Venerol. 2017;154(1):64–71. doi: 10.23736/S0392-0488.17.05801-1

[90] Paolino G., Moliterni E., Corsetti P., et al. Vitamin D and melanoma: state of the art and possible therapeutic uses // Ital Dermatol Venerol. 2017. Vol. 154, N 1. P. 64–71. doi: 10.23736/S0392-0488.17.05801-1

[91] Priemel M, von Domarus C, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25(2):305–312. doi: 10.1359/jbmr.090728

[92] Priemel M., von Domarus C., Klatte T.O., et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients // J Bone Miner Res. 2010. Vol. 25, N 2. P. 305–312. doi: 10.1359/jbmr.090728

[93] Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40–49. doi: 10.1056/NEJMoa1109617

[94] Bischoff-Ferrari H.A., Willett W.C., Orav E.J., et al. A pooled analysis of vitamin D dose requirements for fracture prevention // N Engl J Med. 2012. Vol. 367, N 1. P. 40–49. doi: 10.1056/NEJMoa1109617

[95] Adami S, Giannini S, Bianchi G, et al. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int. 2009;20(2):239–244. doi: 10.1007/s00198-008-0650-y

[96] Adami S., Giannini S., Bianchi G., et al. Vitamin D status and response to treatment in post-menopausal osteoporosis // Osteoporos Int. 2009. Vol. 20, N 2. P. 239–244. doi: 10.1007/s00198-008-0650-y

[97] Cosman F, Dawson-Hughes B, Wan X, Krege JH. Changes in vitamin D metabolites during teriparatide treatment. Bone. 2012;50(6):1368–1371.

[98] Cosman F., Dawson-Hughes B., Wan X., Krege J.H. Changes in vitamin D metabolites during teriparatide treatment // Bone. 2012. Vol. 50, N 6. P. 1368–1371.

[99] Cauley JA, Greendale GA, Ruppert K, et al. Serum 25 hydroxyvitamin D, bone mineral density and fracture risk across the menopause. J Clin Endocrinol Metab. 2015;100(5):2046–2054.

[100] Cauley J.A., Greendale G.A., Ruppert K., et al. Serum 25 hydroxyvitamin D, bone mineral density and fracture risk across the menopause // J Clin Endocrinol Metab. 2015. Vol. 100, N 5. P. 2046–2054.

[101] Bikle DD. Do sunscreens block vitamin D production? A critical review by an international panel of experts. Br J Dermatol. 2019;181(5):884. doi: 10.1111/bjd.18126

[102] Bikle D.D. Do sunscreens block vitamin D production? A critical review by an international panel of experts // Br J Dermatol. 2019. Vol. 181, N 5. P. 884. doi: 10.1111/bjd.18126

[103] De Gruijl FR, Webb AR, Rhodes LE. Everyday sunscreen use may compromise vitamin D in temperate climes. Br J Dermatol. 2020;182(5):1312–1313. doi: 10.1111/bjd.18811

[104] De Gruijl F.R., Webb A.R., Rhodes L.E. Everyday sunscreen use may compromise vitamin D in temperate climes // Br J Dermatol. 2020. Vol. 182, N 5. P. 1312–1313. doi: 10.1111/bjd.18811

[105] Kannan S, Lim HW. Photoprotection and vitamin D: a review. Photodermatol Photoimmunol Photomed. 2014;30:137–145.

[106] Kannan S., Lim H.W. Photoprotection and vitamin D: a review // Photodermatol Photoimmunol Photomed. 2014. Vol. 30. Р. 137–145.

RIGHTS & PERMISSIONS

Eco-Vector